Ubs Group Ag Second Sight Medical Products Inc Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$1.22 - $2.57 $6,441 - $13,569	5,280 Added 6857.14%	5,357 $11,000
Q1 2022 May 16, 2022	SELL	$1.16 - $1.83 $3,568 - $5,629	-3,076 Reduced 97.56%	77 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.41 $5,013 - $10,489	3,076 Added 3994.81%	3,153 $5,000
Q2 2021 Aug 13, 2021	SELL	$4.94 - $9.43 $11,258 - $21,490	-2,279 Reduced 96.73%	77 $0
Q1 2021 May 12, 2021	BUY	$1.43 - $15.48 $3,258 - $35,278	2,279 Added 2959.74%	2,356 $20,000
Q4 2020 Feb 11, 2021	SELL	$0.73 - $3.22 $65,500 - $288,920	-89,727 Reduced 99.91%	77 $0
Q3 2020 Nov 12, 2020	BUY	$0.73 - $1.04 $63,716 - $90,774	87,283 Added 3462.24%	89,804 $77,000
Q2 2020 Jul 31, 2020	BUY	$0.8 - $2.1 $1,955 - $5,132	2,444 Added 3174.03%	2,521 $2,000
Q1 2020 May 01, 2020	BUY	$1.0 - $6.05 $77 - $465	77 New	77 $0

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.